Taisho Pharmaceutical Holdings Co., Ltd. Stock price

Equities

4581

JP3442850008

Pharmaceuticals

Market Closed - Japan Exchange 06:00:00 21/02/2024 GMT 5-day change 1st Jan Change
8,594 JPY 0.00% Intraday chart for Taisho Pharmaceutical Holdings Co., Ltd. -0.07% -0.59%

Financials

Sales 2024 * 318B 2.12B 168B Sales 2025 * 326B 2.17B 172B Capitalization 704B 4.69B 372B
Net income 2024 * 9.3B 61.95M 4.92B Net income 2025 * 18.1B 121M 9.57B EV / Sales 2024 * 1.39 x
Net cash position 2024 * 261B 1.74B 138B Net cash position 2025 * 279B 1.86B 147B EV / Sales 2025 * 1.3 x
P/E ratio 2024 *
75.8 x
P/E ratio 2025 *
38.9 x
Employees 8,784
Yield 2024 *
1.16%
Yield 2025 *
1.16%
Free-Float 53.87%
More Fundamentals * Assessed data
Dynamic Chart
Oasis says it opposes Taisho Pharma's $5 bln management buyout RE
What is the Tokyo Exchange's new list of firms disclosing capital efficiency plans? RE
Otemon Co., Ltd. completed the acquisition of 73.12% stake in Taisho Pharmaceutical Holdings Co., Ltd. for approximately ¥520 billion. CI
Linqmed Inc. announced that it has received ¥680 million in funding from a group of investors CI
Mizuho sees 'urgency' as Japan Inc scurries to bolster capital in line with TSE RE
Nikkei ends lower as investors book profits, yen rebound weighs RE
Nikkei trades lower as investors book profits, yen rebound weighs RE
Japan's Nikkei ends lower on caution ahead of US inflation data RE
Japan's Nikkei surrenders early gains as investors lock in profits RE
Otemon Co., Ltd. made an offer to acquire Taisho Pharmaceutical Holdings Co., Ltd. for ¥8620. CI
Biolinq Inc and Taisho Pharmaceutical Announce Strategic Collaboration and Exclusive License Agreement in Japan CI
Jefferies Adjusts Taisho Pharmaceutical's Price Target to 5,600 Yen From 5,200 Yen, Keeps at Hold MT
Taisho Pharmaceutical Holdings Co., Ltd. entered into an agreement to acquire Bonviva Business from Chugai Pharmaceutical Co., Ltd. and F. Hoffmann-La Roche. CI
Jupiter Wellness Says It Has Secured Notice of Allowance From US Patent Office for Application Related to Minoxidil Adjuvant Therapies MT
SOXAI Inc. announced that it has received ¥315 million in funding from Taisho Pharmaceutical Holdings Co., Ltd., Resona Capital Co., Ltd., SPARX Group Co., Ltd., PKSHA Technology Capital LLC CI
More news
1 week+0.05%
Current month-0.09%
1 month-0.14%
3 months+55.77%
6 months+43.07%
Current year-0.59%
More quotes
1 week
8 586.00
Extreme 8586
8 607.00
1 month
8 583.00
Extreme 8583
8 640.00
Current year
8 570.00
Extreme 8570
8 677.00
1 year
5 150.00
Extreme 5150
8 753.00
3 years
4 560.00
Extreme 4560
8 753.00
5 years
4 560.00
Extreme 4560
11 440.00
10 years
4 560.00
Extreme 4560
14 130.00
More quotes
Managers TitleAgeSince
Director of Finance/CFO - -
President 82 02/10/11
Chief Tech/Sci/R&D Officer 46 02/10/11
Members of the board TitleAgeSince
Director/Board Member 82 02/10/11
President 82 02/10/11
Director/Board Member 77 02/10/11
More insiders
Date Price Change Volume
21/02/24 8,594 0.00% 75 900
20/02/24 8,594 +0.01% 242,300
19/02/24 8,593 +0.02% 94,600
16/02/24 8,591 -0.05% 125,200
15/02/24 8,595 +0.06% 119,300

Delayed Quote Japan Exchange, February 21, 2024 at 06:00 am

More quotes
Taisho Pharmaceutical Holdings Co Ltd is a Japan-based company mainly engaged in the research, development, manufacture and sale of over-the-counter drugs, quasi-drugs, foods, medical supplies, hygiene products, and ethical drugs. The Company operates in two business segments. The Self-Medication segment is engaged in the research, development, manufacture and sale of over-the-counter drugs, quasi-drugs, foods, medical supplies, hygiene products. The Pharmaceutical segment is engaged in the research, development, manufacture and sale of ethical drugs. The other business is engaged in the leasing and management of real estate, as well as hotel management business.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
8,594 JPY
Average target price
6,180 JPY
Spread / Average Target
-28.09%
Consensus
  1. Stock
  2. Equities
  3. Stock Taisho Pharmaceutical Holdings Co., Ltd. - Japan Exchange
+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019
Replicate our performance
fermer